Champions Oncology, Inc. (CSBR) Financials

CSBR Assets vs Liabilities
DateAssetsLiabilities
July 31, 2026 33.3 million 28.8 million
April 30, 2026 27.0 million 22.9 million
Jan. 31, 2026 28.4 million 24.1 million
Oct. 31, 2025 30.2 million 25.9 million

CSBR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
July 31, 2026 -547000 766000
April 30, 2026 -2.2 million 357000
Jan. 31, 2026 -1.4 million 423000
Oct. 31, 2025 -2.0 million 249000

CSBR Net Income

No data available :(

CSBR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
July 31, 2026 4.4 million - 10.1 million
April 30, 2026 4.9 million - 3.0 million
Jan. 31, 2026 7.1 million - 3.4 million
Oct. 31, 2025 8.5 million - 5.3 million

CSBR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
July 31, 2026 13.9 million
April 30, 2026 13.8 million
Jan. 31, 2026 13.9 million
Oct. 31, 2025 14.5 million

CSBR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
July 31, 2026 55000 2.3 million 5.8 million 3.1 million
April 30, 2026 239000 2.1 million 5.4 million 2.8 million
Jan. 31, 2026 37000 2.3 million 5.6 million 2.7 million
Oct. 31, 2025 242000 2.6 million 5.0 million 2.0 million

CSBR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
July 31, 2026 15.2 million 7.8 million
April 30, 2026 13.8 million 6.8 million
Jan. 31, 2026 16.6 million 8.8 million
Oct. 31, 2025 15.0 million 7.3 million

CSBR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CSBR

Price: $4.85

52 week price:
4.59
9.63

Earnings Per Share: -0.08 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4300

Ebitda: -4.7 million

Market Capitalization: 68.6 million

Links: